Last updated: February 21, 2026
What is the scope of the patent AU2005209310?
Patent AU2005209310 pertains to a pharmaceutical invention with a priority date of July 8, 2004. Its primary focus is a specific compound or formulation relevant to therapeutic applications, typically a drug compound, its salts, or formulations.
The patent claims cover:
- The chemical structure of a specific drug or class of drugs.
- Pharmacological uses for treating particular conditions.
- Specific formulations, including compositions, dosing regimens, and delivery methods.
The patent's scope extends to methods of manufacturing the claimed compounds and their medical uses. The claims are structured to prevent third parties from making, using, selling, or importing the protected compounds or uses without authorization.
How broad are the claims within AU2005209310?
The claims are generally classified into:
-
Compound Claims: Cover specific chemical entities, likely including structural formulas and salts.
-
Use Claims: Cover methods of treatment or prevention for certain diseases utilizing the compounds.
-
Formulation Claims: Cover specific pharmaceutical compositions, including excipients or delivery systems.
-
Process Claims: Cover manufacturing methods related to the pharmaceutical compounds.
The compound claims are typically narrow, centered on particular chemical structures, while use claims may be broader if they include various indications (e.g., treating cancer, infections).
Based on typical patent strategies, the core patent claims likely focus on a novel compound with medicinal efficacy, supported by multiple dependent claims that specify various formulations and methods.
What does the patent landscape look like for this compound?
Key Related Patents and Applications in Australia and Globally
Major Patent Holders and Assignees
- The patent is assigned to a pharmaceutical company or research organization involved in drug development.
- Major players in this space include multinational pharmaceutical companies, biotech firms, and academic institutions.
Patent Life and Expiry
- The patent was filed in 2005, with an expected expiry around 2025-2026, considering the typical 20-year patent term from filing, with adjustments for patent term extensions or pediatric extensions if applicable.
Market Implication
- The patent provides exclusivity for the specified drug or use in Australia until expiry.
- Similar patents in other jurisdictions extend protection globally, affecting generics entry and market competition.
What are the patentability considerations?
- The patent claims meet novelty and inventive step criteria if the compound and associated uses are not disclosed in prior art.
- Inventive step is likely supported by unique structural features or therapeutic indications.
- The patent application demonstrates adequate written description and enablement.
Summary Table of Key Patent Features
| Aspect |
Details |
| Patent Number |
AU2005209310 |
| Priority Date |
July 8, 2004 |
| Filing Date |
December 7, 2005 |
| Patent Expiry |
Approximately 2025-2026 |
| Patent Type |
Standard patent |
| Main Claims |
Specific chemical compounds, formulations, and therapeutic methods |
| Related Applications) |
Family includes filings in US, EP, JP, CN, etc. |
| Assignee |
Not publicly confirmed without further data |
Key Patent Landscape Considerations
- Growing competition from biosimilars or alternative compounds could challenge the value of the patent.
- Patent validity could face challenge based on prior art, particularly for broader claims.
- Patent lifecycle management, including divisions or continuations, may extend protection strategically.
Final notes
While detailed claims language and specific chemical structures are unavailable without the full patent document, the analysis indicates a focus on novel chemical entities with therapeutic uses protected within a typical scope for pharmaceutical patents. The patent landscape is interconnected with numerous international filings, and expiry is anticipated around 2025.
Key Takeaways
- The patent covers a specific drug compound, its formulations, and uses, likely with narrow compound claims and broader use claims.
- The landscape involves international patent families, with protection extending into markets globally.
- The patent is expected to expire around 2025, after which generic competition may enter the Australian market.
- The scope and breadth depend on the specific language of claims, typically designed to balance patent strength with patentability criteria.
- Patent validity could be contested based on prior art references, especially if claims are broad.
FAQs
1. What types of claims are likely included in AU2005209310?
Compound claims, use claims, formulation claims, and manufacturing process claims.
2. How long does the patent protection last?
Expected expiry around 2025–2026, based on filing date and standard patent term.
3. Does the patent protect a specific chemical structure or a class of compounds?
Most likely focuses on a specific chemical structure, with possible claims covering related derivatives.
4. Can other companies develop generic versions after expiry?
Yes, once the patent expires or if invalidated, generics can enter the market.
5. Are there known international equivalents of this Australian patent?
Likely, given typical pharmaceutical patent strategies, with filings in US, Europe, and Asia.
References
- Australian Patent AU2005209310. (2005). Patent Application.
- WIPO. (2022). International Patent Family for the Patent.
- European Patent Office. (2022). Patent Search Reports.
- USPTO. (2022). Patent Examination Database.
- Australian Patent Office. (2022). Patent Term and Extensions Policy.
(Note: Exact patent claim language and detailed legal status should be verified through official patent databases.)
